Cramer's charts suggest big-name biotech stocks Gilead and Celgene have more room to run

7:01 PM ET Tue, 17 July 2018

Jim Cramer and technician Bob Lang inspect the charts to see if big-cap biotechnology stocks like Gilead and Celgene could have more room to run.